Loading...
•
Dec 31, 2021
CVS Health Q4 2021 Earnings Report
Reported strong Q4 and full-year results, confirming full-year EPS guidance for 2022.
Key Takeaways
CVS Health's Q4 2021 total revenues increased to $76.6 billion, up 10.1% compared to the prior year. GAAP diluted EPS was $0.98, and adjusted EPS was $1.98. The company administered over 8 million COVID-19 tests and 20 million vaccines in Q4 2021.
Total revenues increased to $76.6 billion, up 10.1% compared to prior year.
GAAP diluted EPS from continuing operations was $0.98, and Adjusted EPS was $1.98.
The company administered more than 8 million COVID-19 tests and more than 20 million COVID-19 vaccines nationwide.
CVS Health unveiled several steps to support the acceleration of the Company’s omnichannel health strategy.
CVS Health
CVS Health
CVS Health Revenue by Segment
Revenue by Segment
Health Care Benefits Revenue
CapyFin.comHealth Services Revenue
CapyFin.comPharmacy & Consumer Wellness Revenue
CapyFin.com Forward Guidance
The Company confirmed its full-year 2022 GAAP diluted EPS from continuing operations guidance range of $7.04 to $7.24 and its full-year 2022 Adjusted EPS guidance range of $8.10 to $8.30. The Company also revised its full-year 2022 cash flow from operations guidance range to $12.0 billion to $13.0 billion from $12.5 billion to $13.0 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income